ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1018
    Monolayer Culture Induced the Expression of Zyxin-Related Protein 1 (ZRP-1), αvβ3 integrin Complex and Leptin in Human Articular Chondrocytes
  • Abstract Number: 1026
    Monosodium Urate Monohydrate Crystals Induces the Expression of Ihh and MMP-13 in ATDC5 Cells: Implications in Osteoarthritis (OA) Development.
  • Abstract Number: L13
    Monthly Ibandronate Reduces Bone Loss in Osteopenic Women with Rheumatoid Arthritis Receiving Long-Term Glucocorticoids: A 48-Week Double-Blinded Randomized Placebo-Controlled Investigator-Initiated Trial
  • Abstract Number: 2646
    Mood Disorders in Systemic Lupus Erythematousus (SLE): Results from an International, Inception Cohort Study
  • Abstract Number: 2969
    Mortality after Knee Replacement Surgery for Osteoarthritis in a Population-Based Propensity-Score Matched Cohort
  • Abstract Number: 2620
    Mortality and Survival in Systemic Lupus Erythematosus Patients: Trends in a Spanish Cohort from 1985 to 2013
  • Abstract Number: 2053
    Mortality Decreases in Patients with Rheumatoid Arthritis: a 15-Year Prospective Cohort Study
  • Abstract Number: 817
    Mortality in a Large Cohort of Patients with Early Rheumatoid Arthritis That Were Treated-to-Target for 10 Years
  • Abstract Number: 1432
    Mortality Ratio of Rheumatoid Arthritis Under Biological Treatment
  • Abstract Number: 1070
    Mortality Risk in Patients with Rheumatoid Arthritis Who Develop Non–Hodgkin′s Lymphoma
  • Abstract Number: 1067
    Mortality Trends in Rheumatoid Arthritis during the Biologic Era, 1998 to 2011
  • Abstract Number: 1106
    Most Patients Diagnosed with Fibromyalgia By Physicians Do Not Have Fibromyalgia: The 2012 National Health Interview Survey Fibromyalgia Study
  • Abstract Number: 2012
    Moving Social Media Beyond Health Education and into Patient Engagement
  • Abstract Number: 2993
    MRI in Neuropsychiatric Lupus: Correlations with the 1999 ACR Case Definitions
  • Abstract Number: 580
    MRI Is Often Negative in Clinically Suspected Non-Radiographic Axial Spondyloarthritis
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 202
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology